Therapies using non-natural amino acids and polypeptides
AssigneeAmbrx, Inc.
InventorsZhenwei Miao, Junjie Liu, Thea Norman, Russell Driver
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmbrx, Inc.
InventorsZhenwei Miao, Junjie Liu, Thea Norman, Russell Driver
Estimating the term…
Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
A method for treating a growth hormone deficiency, comprising administering to a subject in need thereof a therapeutically effective amount of human growth hormone (hGH), having at least one non-natural amino acid in the B-C loop, the A-B loop, the C-D loop, proximal to helix A, or distal to the final helix of human growth hormone (hGH), wherein the at least one non-natural amino acid has the structure:
Dependencies are inferred from the claim text.